SCHEMBL6172178

SCHEMBL6172178

CCN(CC)CCOC(=O)Nc1cnccc1C(C)C1NC(=O)N(c2ccc(SC(F)(F)F)cc2)C1=O

nearest known ligand 0.33

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 3/20 0.33
MCHR1 Q99705 1/20 0.32
NTRK1 P04629 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6171505 0.90 IGF1R (0.34) IGF1RNTRK1
SCHEMBL6174745 0.85 IGF1R (0.34) IGF1RNTRK1
SCHEMBL6175146 0.83 LMNA (0.39) IGF1RNTRK1
SCHEMBL6174445 0.83 IGF1R (0.43) IGF1RMCHR1
SCHEMBL6173495 0.80 KCNK2 (0.41)
SCHEMBL6173990 0.79 IGF1R (0.39) IGF1R
SCHEMBL6174079 0.79 KCNK2 (0.45)
SCHEMBL6174730 0.79 RXFP1 (0.39) IGF1R
SCHEMBL6173749 0.79 KCNK2 (0.42) IGF1R
SCHEMBL6171775 0.79 IGF1R (0.38) IGF1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed